Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000727205 | SCV000604175 | benign | not provided | 2023-10-20 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000727205 | SCV000706601 | uncertain significance | not provided | 2017-02-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000727205 | SCV000975438 | likely benign | not provided | 2018-06-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000084150 | SCV001717441 | benign | Familial Mediterranean fever | 2023-10-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000727205 | SCV004700194 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | MEFV: BS1 |
Unité médicale des maladies autoinflammatoires, |
RCV000084150 | SCV000116281 | not provided | Familial Mediterranean fever | no assertion provided | not provided | ||
Natera, |
RCV001274312 | SCV001458299 | benign | Familial Mediterranean fever, autosomal dominant | 2020-06-04 | no assertion criteria provided | clinical testing |